Tag Archives: Strengthening Compliance

Fixed-Dose Combination of Memantine Extended Release and Donepezil for Alzheimer’s Disease: Licensing Application Submitted to FDA (Biospace Inc.)

Summary A new drug application has been submitted to the FDA (in the United States) for a fixed-dose combination of memantine extended release and donepezil for the treatment of moderate to severe Alzheimer’s Disease dementia. “Using the two drugs together … Continue reading

Posted in For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), International, Management of Condition, Pharmacological Treatments, Quick Insights | Tagged , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Innovation Health and Wealth (IHW): One Year On (Department of Health)

Summary This report gives an update on the implementation of the NHS Chief Executive’s “Innovation health and wealth: accelerating adoption and diffusion in the NHS” report, published in December 2011, defining the Department of Health’s agenda for delivering innovation throughout the … Continue reading

Posted in Commissioning, Community Care, Department of Health, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), Management of Condition, National, NHS, Quick Insights, Standards, Telecare, Telehealth, UK, Universal Interest | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment